Similar Articles
The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.
D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN
Clinical Scales for Multiple Sclerosis
Kadriye ARMUTLU, Rana KARABUDAK
HLA Tissue Antigens in Multiple Sclerosis
Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL
Serum Vitamin B12 and Folate Levels in Multiple Sclerosis
H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER
Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.
Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM
THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS
Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA
Multiple Sclerosis Cases with Atypical Signs
Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY
Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population
Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy
DOI: 10.4274/tnd.2021.63444
Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis
Rana KARABUDAK
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports
Murat TERZİ
Assesment of quality of life in neurological diseases
Sibel Karşıdağ, Yasemin Ekmekyapar Fırat, Fettah Eren, Sibel Canbaz Kabay, Murat Terzi
DOI: 10.4274/tnd.2023.56649
The influence of self-care agency on quality of life in patients with multiple sclerosis
Ahsen Taştan Gürkan, Afitap Özdelikara
DOI: 10.55697/tnd.2024.9
Determination of important predictors for the fifth-year Expanded Disability Status Scale scores of patients with multiple sclerosis using machine learning
İlknur Buçan Kırkbir, Burçin Kurt, Cavit Boz, Murat Terzi
DOI: 10.55697/tnd.2024.107